nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinchocaine—Lucanthone—TOP1—systemic scleroderma	0.088	1	CrCbGaD
Cinchocaine—CALM2—artery—systemic scleroderma	0.0362	0.0829	CbGeAlD
Cinchocaine—CALM1—artery—systemic scleroderma	0.0361	0.0825	CbGeAlD
Cinchocaine—CALM2—endothelium—systemic scleroderma	0.0306	0.07	CbGeAlD
Cinchocaine—CALM1—endothelium—systemic scleroderma	0.0305	0.0697	CbGeAlD
Cinchocaine—CALM2—blood vessel—systemic scleroderma	0.0282	0.0645	CbGeAlD
Cinchocaine—CALM1—blood vessel—systemic scleroderma	0.0281	0.0642	CbGeAlD
Cinchocaine—CALM3—smooth muscle tissue—systemic scleroderma	0.0169	0.0386	CbGeAlD
Cinchocaine—SCN5A—digestive system—systemic scleroderma	0.0154	0.0352	CbGeAlD
Cinchocaine—CALM2—connective tissue—systemic scleroderma	0.0145	0.0331	CbGeAlD
Cinchocaine—CALM1—connective tissue—systemic scleroderma	0.0144	0.0329	CbGeAlD
Cinchocaine—SCN10A—lung—systemic scleroderma	0.0141	0.0324	CbGeAlD
Cinchocaine—CALM2—smooth muscle tissue—systemic scleroderma	0.0132	0.0303	CbGeAlD
Cinchocaine—CALM1—smooth muscle tissue—systemic scleroderma	0.0132	0.0301	CbGeAlD
Cinchocaine—CALM2—skin of body—systemic scleroderma	0.0131	0.0299	CbGeAlD
Cinchocaine—CALM1—skin of body—systemic scleroderma	0.013	0.0297	CbGeAlD
Cinchocaine—CALM3—tendon—systemic scleroderma	0.0127	0.029	CbGeAlD
Cinchocaine—CALM3—lung—systemic scleroderma	0.0111	0.0254	CbGeAlD
Cinchocaine—BCHE—smooth muscle tissue—systemic scleroderma	0.011	0.0252	CbGeAlD
Cinchocaine—BCHE—skin of body—systemic scleroderma	0.0109	0.0249	CbGeAlD
Cinchocaine—CALM2—digestive system—systemic scleroderma	0.0104	0.0239	CbGeAlD
Cinchocaine—CALM1—digestive system—systemic scleroderma	0.0104	0.0238	CbGeAlD
Cinchocaine—CALM2—tendon—systemic scleroderma	0.00994	0.0227	CbGeAlD
Cinchocaine—CALM1—tendon—systemic scleroderma	0.0099	0.0226	CbGeAlD
Cinchocaine—CALM2—lung—systemic scleroderma	0.00873	0.02	CbGeAlD
Cinchocaine—BCHE—digestive system—systemic scleroderma	0.00871	0.0199	CbGeAlD
Cinchocaine—CALM1—lung—systemic scleroderma	0.00869	0.0199	CbGeAlD
Cinchocaine—BCHE—lung—systemic scleroderma	0.00728	0.0166	CbGeAlD
Cinchocaine—SCN10A—Developmental Biology—RHOB—systemic scleroderma	0.0033	0.00696	CbGpPWpGaD
Cinchocaine—SCN5A—Axon guidance—RHOB—systemic scleroderma	0.00325	0.00685	CbGpPWpGaD
Cinchocaine—CALM3—Cellular roles of Anthrax toxin—IL1B—systemic scleroderma	0.00323	0.0068	CbGpPWpGaD
Cinchocaine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.00319	0.00672	CbGpPWpGaD
Cinchocaine—CALM3—VEGFR2 mediated vascular permeability—NOS3—systemic scleroderma	0.00313	0.00659	CbGpPWpGaD
Cinchocaine—CALM2—Cellular roles of Anthrax toxin—IL1B—systemic scleroderma	0.00312	0.00658	CbGpPWpGaD
Cinchocaine—CALM1—Cellular roles of Anthrax toxin—IL1B—systemic scleroderma	0.00312	0.00658	CbGpPWpGaD
Cinchocaine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.00309	0.00651	CbGpPWpGaD
Cinchocaine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.00309	0.00651	CbGpPWpGaD
Cinchocaine—CALM3—VEGFR1 specific signals—NOS3—systemic scleroderma	0.00304	0.00641	CbGpPWpGaD
Cinchocaine—CALM2—VEGFR2 mediated vascular permeability—NOS3—systemic scleroderma	0.00303	0.00638	CbGpPWpGaD
Cinchocaine—CALM1—VEGFR2 mediated vascular permeability—NOS3—systemic scleroderma	0.00303	0.00638	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.00296	0.00624	CbGpPWpGaD
Cinchocaine—CALM2—VEGFR1 specific signals—NOS3—systemic scleroderma	0.00294	0.0062	CbGpPWpGaD
Cinchocaine—CALM1—VEGFR1 specific signals—NOS3—systemic scleroderma	0.00294	0.0062	CbGpPWpGaD
Cinchocaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—systemic scleroderma	0.00285	0.006	CbGpPWpGaD
Cinchocaine—CALM1—Endothelin Pathways—NOS3—systemic scleroderma	0.00266	0.00559	CbGpPWpGaD
Cinchocaine—CALM2—Endothelin Pathways—NOS3—systemic scleroderma	0.00266	0.00559	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—RHOB—systemic scleroderma	0.00232	0.00489	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by EGFR—CSK—systemic scleroderma	0.00208	0.00437	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.00206	0.00435	CbGpPWpGaD
Cinchocaine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.00206	0.00435	CbGpPWpGaD
Cinchocaine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.00206	0.00435	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.00206	0.00434	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by EGFR—CSK—systemic scleroderma	0.00201	0.00423	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by EGFR—CSK—systemic scleroderma	0.00201	0.00423	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.002	0.0042	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.002	0.0042	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.00199	0.00419	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.00199	0.00419	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.00193	0.00406	CbGpPWpGaD
Cinchocaine—CALM3—IFN-gamma pathway—IL1B—systemic scleroderma	0.00189	0.00398	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.00186	0.00393	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.00186	0.00393	CbGpPWpGaD
Cinchocaine—CALM2—IFN-gamma pathway—IL1B—systemic scleroderma	0.00183	0.00385	CbGpPWpGaD
Cinchocaine—CALM1—IFN-gamma pathway—IL1B—systemic scleroderma	0.00183	0.00385	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.00176	0.0037	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.0017	0.00358	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.0017	0.00358	CbGpPWpGaD
Cinchocaine—CALM3—B Cell Activation—BLK—systemic scleroderma	0.00169	0.00355	CbGpPWpGaD
Cinchocaine—CALM1—B Cell Activation—BLK—systemic scleroderma	0.00163	0.00344	CbGpPWpGaD
Cinchocaine—CALM2—B Cell Activation—BLK—systemic scleroderma	0.00163	0.00344	CbGpPWpGaD
Cinchocaine—CALM3—Carbohydrate metabolism—HSPG2—systemic scleroderma	0.0016	0.00337	CbGpPWpGaD
Cinchocaine—CALM2—Carbohydrate metabolism—HSPG2—systemic scleroderma	0.00155	0.00326	CbGpPWpGaD
Cinchocaine—CALM1—Carbohydrate metabolism—HSPG2—systemic scleroderma	0.00155	0.00326	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.00155	0.00326	CbGpPWpGaD
Cinchocaine—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—systemic scleroderma	0.00154	0.00324	CbGpPWpGaD
Cinchocaine—SCN10A—Axon guidance—MMP2—systemic scleroderma	0.00154	0.00324	CbGpPWpGaD
Cinchocaine—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—systemic scleroderma	0.00149	0.00314	CbGpPWpGaD
Cinchocaine—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—systemic scleroderma	0.00149	0.00314	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.00132	0.00279	CbGpPWpGaD
Cinchocaine—CALM2—Endochondral Ossification—MMP9—systemic scleroderma	0.00125	0.00264	CbGpPWpGaD
Cinchocaine—CALM1—Endochondral Ossification—MMP9—systemic scleroderma	0.00125	0.00264	CbGpPWpGaD
Cinchocaine—CALM2—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.00117	0.00246	CbGpPWpGaD
Cinchocaine—CALM1—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.00117	0.00246	CbGpPWpGaD
Cinchocaine—CALM3—Alzheimers Disease—IL1B—systemic scleroderma	0.00116	0.00245	CbGpPWpGaD
Cinchocaine—SCN10A—Axon guidance—MMP9—systemic scleroderma	0.00116	0.00243	CbGpPWpGaD
Cinchocaine—CALM1—Alzheimers Disease—IL1B—systemic scleroderma	0.00112	0.00237	CbGpPWpGaD
Cinchocaine—CALM2—Alzheimers Disease—IL1B—systemic scleroderma	0.00112	0.00237	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—MMP2—systemic scleroderma	0.0011	0.00231	CbGpPWpGaD
Cinchocaine—SCN5A—Axon guidance—MMP2—systemic scleroderma	0.00108	0.00228	CbGpPWpGaD
Cinchocaine—CALM3—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.00107	0.00226	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—SELP—systemic scleroderma	0.00106	0.00224	CbGpPWpGaD
Cinchocaine—CALM1—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.00104	0.00218	CbGpPWpGaD
Cinchocaine—CALM2—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.00104	0.00218	CbGpPWpGaD
Cinchocaine—CALM1—Endochondral Ossification—TGFB1—systemic scleroderma	0.00103	0.00218	CbGpPWpGaD
Cinchocaine—CALM2—Endochondral Ossification—TGFB1—systemic scleroderma	0.00103	0.00218	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—SELP—systemic scleroderma	0.00103	0.00217	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—SELP—systemic scleroderma	0.00103	0.00217	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by VEGF—NOS3—systemic scleroderma	0.00101	0.00213	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.001	0.00211	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—RHOB—systemic scleroderma	0.000993	0.00209	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by VEGF—NOS3—systemic scleroderma	0.000978	0.00206	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by VEGF—NOS3—systemic scleroderma	0.000978	0.00206	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—RHOB—systemic scleroderma	0.000961	0.00202	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—RHOB—systemic scleroderma	0.000961	0.00202	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—CSK—systemic scleroderma	0.000905	0.00191	CbGpPWpGaD
Cinchocaine—CALM3—Platelet degranulation—TGFB1—systemic scleroderma	0.000894	0.00188	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—CSK—systemic scleroderma	0.000875	0.00184	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—CSK—systemic scleroderma	0.000875	0.00184	CbGpPWpGaD
Cinchocaine—CALM1—Platelet degranulation—TGFB1—systemic scleroderma	0.000865	0.00182	CbGpPWpGaD
Cinchocaine—CALM2—Platelet degranulation—TGFB1—systemic scleroderma	0.000865	0.00182	CbGpPWpGaD
Cinchocaine—CALM3—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000851	0.00179	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—ITGAM—systemic scleroderma	0.000851	0.00179	CbGpPWpGaD
Cinchocaine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000831	0.00175	CbGpPWpGaD
Cinchocaine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000831	0.00175	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—MMP9—systemic scleroderma	0.000824	0.00174	CbGpPWpGaD
Cinchocaine—CALM2—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000824	0.00173	CbGpPWpGaD
Cinchocaine—CALM1—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000824	0.00173	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—ITGAM—systemic scleroderma	0.000823	0.00173	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—ITGAM—systemic scleroderma	0.000823	0.00173	CbGpPWpGaD
Cinchocaine—SCN5A—Axon guidance—MMP9—systemic scleroderma	0.000812	0.00171	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of proteins—ACE—systemic scleroderma	0.000811	0.00171	CbGpPWpGaD
Cinchocaine—CALM3—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000796	0.00168	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CSK—systemic scleroderma	0.000782	0.00165	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—MMP2—systemic scleroderma	0.000771	0.00162	CbGpPWpGaD
Cinchocaine—CALM2—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.00077	0.00162	CbGpPWpGaD
Cinchocaine—CALM1—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.00077	0.00162	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—ITGAM—systemic scleroderma	0.000766	0.00161	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CD247—systemic scleroderma	0.000766	0.00161	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CSK—systemic scleroderma	0.000757	0.00159	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CSK—systemic scleroderma	0.000757	0.00159	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CD247—systemic scleroderma	0.000741	0.00156	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CD247—systemic scleroderma	0.000741	0.00156	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—ITGAM—systemic scleroderma	0.000741	0.00156	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—ITGAM—systemic scleroderma	0.000741	0.00156	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CD247—systemic scleroderma	0.000735	0.00155	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—TNFAIP3—systemic scleroderma	0.000717	0.00151	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CD247—systemic scleroderma	0.000711	0.0015	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CD247—systemic scleroderma	0.000711	0.0015	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—TNFAIP3—systemic scleroderma	0.000694	0.00146	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—TNFAIP3—systemic scleroderma	0.000694	0.00146	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—BLK—systemic scleroderma	0.00068	0.00143	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—TGFB1—systemic scleroderma	0.000679	0.00143	CbGpPWpGaD
Cinchocaine—CALM3—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000678	0.00143	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—BLK—systemic scleroderma	0.000658	0.00139	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—BLK—systemic scleroderma	0.000658	0.00139	CbGpPWpGaD
Cinchocaine—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000655	0.00138	CbGpPWpGaD
Cinchocaine—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000655	0.00138	CbGpPWpGaD
Cinchocaine—CALM3—Disease—SMAD7—systemic scleroderma	0.000622	0.00131	CbGpPWpGaD
Cinchocaine—CALM2—Disease—SMAD7—systemic scleroderma	0.000601	0.00127	CbGpPWpGaD
Cinchocaine—CALM1—Disease—SMAD7—systemic scleroderma	0.000601	0.00127	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—HSPG2—systemic scleroderma	0.00059	0.00124	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—MMP9—systemic scleroderma	0.00058	0.00122	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—RHOB—systemic scleroderma	0.00057	0.0012	CbGpPWpGaD
Cinchocaine—CALM3—Disease—TGFBI—systemic scleroderma	0.000569	0.0012	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CTLA4—systemic scleroderma	0.000557	0.00117	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—RHOB—systemic scleroderma	0.000551	0.00116	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—RHOB—systemic scleroderma	0.000551	0.00116	CbGpPWpGaD
Cinchocaine—CALM2—Disease—TGFBI—systemic scleroderma	0.00055	0.00116	CbGpPWpGaD
Cinchocaine—CALM1—Disease—TGFBI—systemic scleroderma	0.00055	0.00116	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CTLA4—systemic scleroderma	0.000539	0.00114	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CTLA4—systemic scleroderma	0.000539	0.00114	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of proteins—MMP1—systemic scleroderma	0.000521	0.0011	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—TGFB1—systemic scleroderma	0.000478	0.00101	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CSK—systemic scleroderma	0.000474	0.000999	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IRF5—systemic scleroderma	0.000467	0.000983	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000459	0.000966	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CSK—systemic scleroderma	0.000459	0.000966	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CSK—systemic scleroderma	0.000459	0.000966	CbGpPWpGaD
Cinchocaine—CALM3—Disease—HSPG2—systemic scleroderma	0.000454	0.000955	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IRF5—systemic scleroderma	0.000451	0.000951	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IRF5—systemic scleroderma	0.000451	0.000951	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—CTGF—systemic scleroderma	0.000447	0.000941	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IRF8—systemic scleroderma	0.000446	0.000939	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—ITGAM—systemic scleroderma	0.000446	0.000939	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CD247—systemic scleroderma	0.000446	0.000939	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000444	0.000935	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000444	0.000935	CbGpPWpGaD
Cinchocaine—CALM1—Disease—HSPG2—systemic scleroderma	0.000439	0.000924	CbGpPWpGaD
Cinchocaine—CALM2—Disease—HSPG2—systemic scleroderma	0.000439	0.000924	CbGpPWpGaD
Cinchocaine—CALM3—Disease—CSK—systemic scleroderma	0.000438	0.000922	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—SMAD7—systemic scleroderma	0.000435	0.000917	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CD40LG—systemic scleroderma	0.000433	0.000913	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—ITGAM—systemic scleroderma	0.000431	0.000909	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—ITGAM—systemic scleroderma	0.000431	0.000909	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CD247—systemic scleroderma	0.000431	0.000909	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CD247—systemic scleroderma	0.000431	0.000909	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IRF8—systemic scleroderma	0.000431	0.000909	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IRF8—systemic scleroderma	0.000431	0.000909	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—MMP1—systemic scleroderma	0.000426	0.000898	CbGpPWpGaD
Cinchocaine—CALM2—Disease—CSK—systemic scleroderma	0.000424	0.000892	CbGpPWpGaD
Cinchocaine—CALM1—Disease—CSK—systemic scleroderma	0.000424	0.000892	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of proteins—CCL2—systemic scleroderma	0.000424	0.000892	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—SMAD7—systemic scleroderma	0.000421	0.000887	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—SMAD7—systemic scleroderma	0.000421	0.000887	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CD40LG—systemic scleroderma	0.000419	0.000883	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CD40LG—systemic scleroderma	0.000419	0.000883	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—TNFAIP3—systemic scleroderma	0.000418	0.00088	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—BLK—systemic scleroderma	0.000413	0.000869	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—MMP1—systemic scleroderma	0.000412	0.000868	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—MMP1—systemic scleroderma	0.000412	0.000868	CbGpPWpGaD
Cinchocaine—CALM3—Disease—CD247—systemic scleroderma	0.000412	0.000867	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—TNFAIP3—systemic scleroderma	0.000404	0.000851	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—TNFAIP3—systemic scleroderma	0.000404	0.000851	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of proteins—MMP2—systemic scleroderma	0.000403	0.000849	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—BLK—systemic scleroderma	0.000399	0.000841	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—BLK—systemic scleroderma	0.000399	0.000841	CbGpPWpGaD
Cinchocaine—CALM2—Disease—CD247—systemic scleroderma	0.000398	0.000839	CbGpPWpGaD
Cinchocaine—CALM1—Disease—CD247—systemic scleroderma	0.000398	0.000839	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000396	0.000835	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000383	0.000808	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000383	0.000808	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—HSPG2—systemic scleroderma	0.00038	0.0008	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—HSPG2—systemic scleroderma	0.000367	0.000774	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—HSPG2—systemic scleroderma	0.000367	0.000774	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CTLA4—systemic scleroderma	0.000338	0.000712	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—RHOB—systemic scleroderma	0.000337	0.000709	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CTLA4—systemic scleroderma	0.000327	0.000689	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CTLA4—systemic scleroderma	0.000327	0.000689	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—RHOB—systemic scleroderma	0.000326	0.000686	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—RHOB—systemic scleroderma	0.000326	0.000686	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	0.000318	0.000669	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—NOS3—systemic scleroderma	0.000309	0.000651	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	0.000307	0.000647	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	0.000307	0.000647	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CSK—systemic scleroderma	0.000307	0.000646	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—NOS3—systemic scleroderma	0.000299	0.000629	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—NOS3—systemic scleroderma	0.000299	0.000629	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CSK—systemic scleroderma	0.000297	0.000625	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CSK—systemic scleroderma	0.000297	0.000625	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	0.000291	0.000613	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—CTGF—systemic scleroderma	0.000288	0.000606	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	0.000282	0.000593	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	0.000282	0.000593	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—CTGF—systemic scleroderma	0.000278	0.000586	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—CTGF—systemic scleroderma	0.000278	0.000586	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—HLA-DQB1—systemic scleroderma	0.000278	0.000586	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—HLA-DQB1—systemic scleroderma	0.000269	0.000567	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—HLA-DQB1—systemic scleroderma	0.000269	0.000567	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL1A—systemic scleroderma	0.000264	0.000557	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CD40LG—systemic scleroderma	0.000263	0.000554	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL1A—systemic scleroderma	0.000256	0.000539	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL1A—systemic scleroderma	0.000256	0.000539	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CD40LG—systemic scleroderma	0.000254	0.000535	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CD40LG—systemic scleroderma	0.000254	0.000535	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—TGFB1—systemic scleroderma	0.000204	0.00043	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	0.000199	0.000419	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—TGFB1—systemic scleroderma	0.000198	0.000416	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—TGFB1—systemic scleroderma	0.000198	0.000416	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—NOS3—systemic scleroderma	0.000195	0.00041	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	0.000192	0.000405	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	0.000192	0.000405	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—EDN1—systemic scleroderma	0.000172	0.000362	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—EDN1—systemic scleroderma	0.000166	0.00035	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—EDN1—systemic scleroderma	0.000166	0.00035	CbGpPWpGaD
Cinchocaine—CALM3—Disease—NOS3—systemic scleroderma	0.00015	0.000315	CbGpPWpGaD
Cinchocaine—CALM1—Disease—NOS3—systemic scleroderma	0.000145	0.000305	CbGpPWpGaD
Cinchocaine—CALM2—Disease—NOS3—systemic scleroderma	0.000145	0.000305	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL1B—systemic scleroderma	0.000138	0.00029	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL1B—systemic scleroderma	0.000133	0.000281	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL1B—systemic scleroderma	0.000133	0.000281	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—NOS3—systemic scleroderma	0.000125	0.000264	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—NOS3—systemic scleroderma	0.000121	0.000255	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—NOS3—systemic scleroderma	0.000121	0.000255	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCL2—systemic scleroderma	0.000118	0.000248	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCL2—systemic scleroderma	0.000114	0.000239	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCL2—systemic scleroderma	0.000114	0.000239	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—NOS3—systemic scleroderma	0.000105	0.000221	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—NOS3—systemic scleroderma	0.000101	0.000213	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—NOS3—systemic scleroderma	0.000101	0.000213	CbGpPWpGaD
Cinchocaine—CALM3—Disease—TGFB1—systemic scleroderma	9.89e-05	0.000208	CbGpPWpGaD
Cinchocaine—CALM2—Disease—TGFB1—systemic scleroderma	9.57e-05	0.000202	CbGpPWpGaD
Cinchocaine—CALM1—Disease—TGFB1—systemic scleroderma	9.57e-05	0.000202	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—MMP9—systemic scleroderma	8.41e-05	0.000177	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—MMP9—systemic scleroderma	8.13e-05	0.000171	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—MMP9—systemic scleroderma	8.13e-05	0.000171	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	6.93e-05	0.000146	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	6.7e-05	0.000141	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	6.7e-05	0.000141	CbGpPWpGaD
